ALINA: a phase III study of alectinib versus chemotherapy as adjuvant therapy in patients with stage IB-IIIA anaplastic lymphoma kinase-positive (ALK +) non-small cell cancer (NSCLC)
暂无分享，去创建一个
A. Shaw | J. Ahn | R. Dziadziuszko | F. Barlesi | M. Nishio | Y. Wu | A. Rittmeyer | W. Bordogna | C. Meyenberg | B. Solomon | Yi‐Long Wu | Benjamin Solomon | Js Ahn | Christoph Meyenberg